MAX is an epigenetic sensor of 5-carboxylcytosine and is altered in multiple myeloma

Nucleic Acids Research

Volumn 45, Issue 5, 2017, Pages 2396-2407

  Wang, Dongxue ^a   Hashimoto, Hideharu ^a   Zhang, Xing ^a,b   Barwick, Benjamin G ^a   Lonial, Sagar ^a,c   Boise, Lawrence H ^a,c   Vertino, Paula M ^a,c   Cheng, Xiaodong ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAX PROTEIN; MYC PROTEIN; 5-CARBOXYLCYTOSINE; ARGININE; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; CYTOSINE; DNA; MNT PROTEIN, HUMAN; PROTEIN BINDING; REPRESSOR PROTEIN;

ARTICLE; CONTROLLED STUDY; CPG ISLAND; CRYSTALLOGRAPHY; DNA BINDING; DNA MODIFICATION; EPIGENETICS; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE MUTATION; HUMAN; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; MULTIPLE MYELOMA; OVERALL SURVIVAL; POLARIZATION; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SITE DIRECTED MUTAGENESIS; ANALOGS AND DERIVATIVES; CHEMISTRY; E BOX ELEMENT; GENETIC EPIGENESIS; GENETICS; METABOLISM; MUTATION; PROTEIN CONFORMATION;

ARGININE; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CPG ISLANDS; CYTOSINE; DNA; E-BOX ELEMENTS; EPIGENESIS, GENETIC; MULTIPLE MYELOMA; MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; REPRESSOR PROTEINS;

EID: 85018323272     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw1184     Document Type: Article

References (68)

1. Lister, R., Pelizzola, M., Dowen, R.H., Hawkins, R.D., Hon, G., Tonti-Filippini, J., Nery, J.R., Lee, L., Ye, Z., Ngo, Q.M. et al. (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature, 462, 315-322.
2. Roadmap Epigenomics, C., Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J. et al. (2015) Integrative analysis of 111 reference human epigenomes. Nature, 518, 317-330.
3. Ziller, M.J., Gu, H., Muller, F., Donaghey, J., Tsai, L.T., Kohlbacher, O., De Jager, P.L., Rosen, E.D., Bennett, D.A., Bernstein, B.E. et al. (2013) Charting a dynamic DNA methylation landscape of the human genome. Nature, 500, 477-481.
4. Hon, G.C., Rajagopal, N., Shen, Y., McCleary, D.F., Yue, F., Dang, M.D. and Ren, B. (2013) Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues. Nat. Genet, 45, 1198-1206.
5. Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L.M., Liu, D.R., Aravind, L. et al. (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science, 324, 930-935.
6. Ito, S., D'Alessio, A.C., Taranova, O.V., Hong, K., Sowers, L.C. and Zhang, Y. (2010) Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature, 466, 1129-1133.
7. Ito, S., Shen, L., Dai, Q., Wu, S.C., Collins, L.B., Swenberg, J.A., He, C. and Zhang, Y. (2011) Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science, 333, 1300-1303.
8. He, Y.F., Li, B.Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L. et al. (2011) Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science, 333, 1303-1307.
9. Bachman, M., Uribe-Lewis, S., Yang, X., Williams, M., Murrell, A. and Balasubramanian, S. (2014) 5-Hydroxymethylcytosine is a predominantly stable DNA modification. Nat. Chem., 6, 1049-1055.
10. Bachman, M., Uribe-Lewis, S., Yang, X., Burgess, H.E., Iurlaro, M., Reik, W., Murrell, A. and Balasubramanian, S. (2015) 5-Formylcytosine can be a stable DNA modification in mammals. Nat. Chem. Biol., 11, 555-557.
11. Hashimoto, H., Zhang, X., Vertino, P.M. and Cheng, X. (2015) The mechanisms of generation, recognition, and erasure of DNA 5-methylcytosine and thymine oxidations. J. Biol. Chem., 290, 20723-20733.
12. Rasmussen, K.D. and Helin, K. (2016) Role of TET enzymes in DNA methylation, development, and cancer. Genes Dev., 30, 733-750.
13. Shen, L., Wu, H., Diep, D., Yamaguchi, S., D'Alessio, A.C., Fung, H.L., Zhang, K. and Zhang, Y. (2013) Genome-wide analysis reveals TETand TDG-dependent 5-methylcytosine oxidation dynamics. Cell, 153, 692-706.
14. Song, C.X., Szulwach, K.E., Dai, Q., Fu, Y., Mao, S.Q., Lin, L., Street, C., Li, Y., Poidevin, M., Wu, H. et al. (2013) Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell, 153, 678-691.
15. Wu, H., Wu, X., Shen, L. and Zhang, Y. (2014) Single-base resolution analysis of active DNA demethylation using methylase-assisted bisulfite sequencing. Nat. Biotechnol., 32, 1231-1240.
16. Lu, X., Han, D., Zhao, B.S., Song, C.X., Zhang, L.S., Dore, L.C. and He, C. (2015) Base-resolution maps of 5-formylcytosine and 5-carboxylcytosine reveal genome-wide DNA demethylation dynamics. Cell Res., 25, 386-389.
17. Sun, Z., Dai, N., Borgaro, J.G., Quimby, A., Sun, D., Correa, I.R. Jr, Zheng, Y., Zhu, Z. and Guan, S. (2015) A sensitive approach to map genome-wide 5-hydroxymethylcytosine and 5-formylcytosine at single-base resolution. Mol. Cell, 57, 750-761.
18. Neri, F., Incarnato, D., Krepelova, A., Rapelli, S., Anselmi, F., Parlato, C., Medana, C., Dal Bello, F. and Oliviero, S. (2015) Single-base resolution analysis of 5-formyl and 5-carboxyl cytosine reveals promoter DNA methylation dynamics. Cell Rep. 10, 674-683.
19. Liu, Y., Toh, H., Sasaki, H., Zhang, X. and Cheng, X. (2012) An atomic model of Zfp57 recognition of CpG methylation within a specific DNA sequence. Genes Dev., 26, 2374-2379.
20. Liu, Y., Olanrewaju, Y.O., Zheng, Y., Hashimoto, H., Blumenthal, R.M., Zhang, X. and Cheng, X. (2014) Structural basis for Klf4 recognition of methylated DNA. Nucleic Acids Res., 42, 4859-4867.
21. Hashimoto, H., Olanrewaju, Y.O., Zheng, Y., Wilson, G.G., Zhang, X. and Cheng, X. (2014) Wilms tumor protein recognizes 5-carboxylcytosine within a specific DNA sequence. Genes Dev., 28, 2304-2313.
22. Golla, J.P., Zhao, J., Mann, I.K., Sayeed, S.K., Mandal, A., Rose, R.B. and Vinson, C. (2014) Carboxylation of cytosine (5caC) in the CG dinucleotide in the E-box motif (CGCAG|GTG) increases binding of the Tcf3|Ascl1 helix-loop-helix heterodimer 10-fold. Biochem. Biophys. Res. Commun., 449, 248-255.
23. Khund Sayeed, S., Zhao, J., Sathyanarayana, B.K., Golla, J.P. and Vinson, C. (2015) C/EBPbeta (CEBPB) protein binding to the C/EBP|CRE DNA 8-mer TTGC|GTCA is inhibited by 5hmC and enhanced by 5mC, 5fC, and 5caC in the CG dinucleotide. Biochim. Biophys. Acta, 1849, 583-589.
24. Wang, L., Zhou, Y., Xu, L., Xiao, R., Lu, X., Chen, L., Chong, J., Li, H., He, C., Fu, X.D. et al. (2015) Molecular basis for 5-carboxycytosine recognition by RNA polymerase II elongation complex. Nature, 523, 621-625.
25. Prendergast, G.C. and Ziff, E.B. (1992) A new bind for Myc. Trends Genet., 8, 91-96.
26. Torres, R., Schreiber-Agus, N., Morgenbesser, S.D. and DePinho, R.A. (1992) Myc and Max: A putative transcriptional complex in search of a cellular target. Curr. Opin. Cell Biol., 4, 468-474.
27. Blackwood, E.M. and Eisenman, R.N. (1991) Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science, 251, 1211-1217.
28. Prendergast, G.C., Lawe, D. and Ziff, E.B. (1991) Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell, 65, 395-407.
29. Lin, C.Y., Loven, J., Rahl, P.B., Paranal, R.M., Burge, C.B., Bradner, J.E., Lee, T.I. and Young, R.A. (2012) Transcriptional amplification in tumor cells with elevated c-Myc. Cell, 151, 56-67.
30. Nie, Z., Hu, G., Wei, G., Cui, K., Yamane, A., Resch, W., Wang, R., Green, D.R., Tessarollo, L., Casellas, R. et al. (2012) c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell, 151, 68-79.
31. Ayer, D.E., Kretzner, L. and Eisenman, R.N. (1993) Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell, 72, 211-222.
32. Diolaiti, D., McFerrin, L., Carroll, P.A. and Eisenman, R.N. (2015) Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis. Biochim. Biophys. Acta, 1849, 484-500.
33. Wang, L.H. and Baker, N.E. (2015) E proteins and ID proteins: Helix-loop-helix partners in development and disease. Dev. Cell, 35, 269-280.
34. Comino-Mendez, I., Gracia-Aznarez, F.J., Schiavi, F., Landa, I., Leandro-Garcia, L.J., Leton, R., Honrado, E., Ramos-Medina, R., Caronia, D., Pita, G. et al. (2011) Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat. Genet., 43, 663-667.
35. Burnichon, N., Cascon, A., Schiavi, F., Morales, N.P., Comino-Mendez, I., Abermil, N., Inglada-Perez, L., de Cubas, A.A., Amar, L., Barontini, M. et al. (2012) MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin. Cancer Res., 18, 2828-2837.
36. Romero, O.A., Torres-Diz, M., Pros, E., Savola, S., Gomez, A., Moran, S., Saez, C., Iwakawa, R., Villanueva, A., Montuenga, L.M. et al. (2014) MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1. Cancer Discov., 4, 292-303.
37. Lan, F., Collins, R.E., De Cegli, R., Alpatov, R., Horton, J.R., Shi, X., Gozani, O., Cheng, X. and Shi, Y. (2007) Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression. Nature, 448, 718-722.
38. Hashimoto, H., Liu, Y., Upadhyay, A.K., Chang, Y., Howerton, S.B., Vertino, P.M., Zhang, X. and Cheng, X. (2012) Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res., 40, 4841-4849.
39. Motulsky, H. and Christopoulos, A. (2004) Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting. Oxford University Press, NY.
40. Kabsch, W. (2010) Xds. Acta Crystallogr. D Biol. Crystallogr., 66, 125-132.
41. Adams, P.D., Afonine, P.V., Bunkoczi, G., Chen, V.B., Davis, I.W., Echols, N., Headd, J.J., Hung, L.W., Kapral, G.J., Grosse-Kunstleve, R.W. et al. (2010) PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr., 66, 213-221.
42. Adams, P.D., Grosse-Kunstleve, R.W., Hung, L.W., Ioerger, T.R., McCoy, A.J., Moriarty, N.W., Read, R.J., Sacchettini, J.C., Sauter, N.K. and Terwilliger, T.C. (2002) PHENIX: Building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr., 58, 1948-1954.
43. Ferre-D'Amare, A.R., Prendergast, G.C., Ziff, E.B. and Burley, S.K. (1993) Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature, 363, 38-45.
44. Nair, S.K. and Burley, S.K. (2003) X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors. Cell, 112, 193-205.
45. Horowitz, S. and Trievel, R.C. (2012) Carbon-oxygen hydrogen bonding in biological structure and function. J. Biol. Chem., 287, 41576-41582.
46. Gao, J., Aksoy, B.A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S.O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E. et al. (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal., 6, pl1.
47. Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., Jacobsen, A., Byrne, C.J., Heuer, M.L., Larsson, E. et al. (2012) The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov., 2, 401-404.
48. Chang, M.T., Asthana, S., Gao, S.P., Lee, B.H., Chapman, J.S., Kandoth, C., Gao, J., Socci, N.D., Solit, D.B., Olshen, A.B. et al. (2016) Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat. Biotechnol., 34, 155-163.
49. Luscombe, N.M., Laskowski, R.A. and Thornton, J.M. (2001) Amino acid-base interactions: A three-dimensional analysis of protein-DNA interactions at an atomic level. Nucleic Acids Res., 29, 2860-2874.
50. Patel, A., Horton, J.R., Wilson, G.G., Zhang, X. and Cheng, X. (2016) Structural basis for human PRDM9 action at recombination hot spots. Genes Dev., 30, 257-265.
51. Boise, L.H., Kaufman, J.L., Bahlis, N.J., Lonial, S. and Lee, K.P. (2014) The Tao of myeloma. Blood, 124, 1873-1879.
52. Affer, M., Chesi, M., Chen, W.D., Keats, J.J., Demchenko, Y.N., Tamizhmani, K., Garbitt, V.M., Riggs, D.L., Brents, L.A., Roschke, A.V. et al. (2014) Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma. Leukemia, 28, 1725-1735.
53. Walker, B.A., Wardell, C.P., Brioli, A., Boyle, E., Kaiser, M.F., Begum, D.B., Dahir, N.B., Johnson, D.C., Ross, F.M., Davies, F.E. et al. (2014) Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients. Blood Cancer J., 4, e191.
54. Lohr, J.G., Stojanov, P., Carter, S.L., Cruz-Gordillo, P., Lawrence, M.S., Auclair, D., Sougnez, C., Knoechel, B., Gould, J., Saksena, G. et al. (2014) Widespread genetic heterogeneity in multiple myeloma: Implications for targeted therapy. Cancer Cell, 25, 91-101.
55. Hon, G.C., Song, C.X., Du, T., Jin, F., Selvaraj, S., Lee, A.Y., Yen, C.A., Ye, Z., Mao, S.Q., Wang, B.A. et al. (2014) 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. Mol. Cell, 56, 286-297.
56. Lu, F., Liu, Y., Jiang, L., Yamaguchi, S. and Zhang, Y. (2014) Role of Tet proteins in enhancer activity and telomere elongation. Genes Dev., 28, 2103-2119.
57. Rampal, R., Alkalin, A., Madzo, J., Vasanthakumar, A., Pronier, E., Patel, J., Li, Y., Ahn, J., Abdel-Wahab, O., Shih, A. et al. (2014) DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia. Cell Rep., 9, 1841-1855.
58. Wang, Y., Xiao, M., Chen, X., Chen, L., Xu, Y., Lv, L., Wang, P., Yang, H., Ma, S., Lin, H. et al. (2015) WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation. Mol. Cell, 57, 662-673.
59. Jin, S.G., Zhang, Z.M., Dunwell, T.L., Harter, M.R., Wu, X., Johnson, J., Li, Z., Liu, J., Szabo, P.E., Lu, Q. et al. (2016) Tet3 reads 5-carboxylcytosine through Its CXXC domain and is a potential guardian against neurodegeneration. Cell Rep., 14, 493-505.
60. Kress, T.R., Sabo, A. and Amati, B. (2015) MYC: Connecting selective transcriptional control to global RNA production. Nat. Rev. Cancer, 15, 593-607.
61. Lorenzin, F., Benary, U., Baluapuri, A., Walz, S., Jung, L.A., von Eyss, B., Kisker, C., Wolf, J., Eilers, M. and Wolf, E. (2016) Different promoter affinities account for specificity in MYC-dependent gene regulation. eLife, 5. e15161.
62. Thomas, L.R., Wang, Q., Grieb, B.C., Phan, J., Foshage, A.M., Sun, Q., Olejniczak, E.T., Clark, T., Dey, S., Lorey, S. et al. (2015) Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC. Mol Cell, 58, 440-452.
63. Link, J.M. and Hurlin, P.J. (2015) The activities of MYC, MNT and the MAX-interactome in lymphocyte proliferation and oncogenesis. Biochim. Biophys. Acta, 1849, 554-562.
64. Vermeer, M.H., van Doorn, R., Dijkman, R., Mao, X., Whittaker, S., van Voorst Vader, P.C., Gerritsen, M.J., Geerts, M.L., Gellrich, S., Soderberg, O. et al. (2008) Novel and highly recurrent chromosomal alterations in Sezary syndrome. Cancer Res., 68, 2689-2698.
65. Edelmann, J., Holzmann, K., Miller, F., Winkler, D., Buhler, A., Zenz, T., Bullinger, L., Kuhn, M.W., Gerhardinger, A., Bloehdorn, J. et al. (2012) High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood, 120, 4783-4794.
66. Ko, M., An, J., Pastor, W.A., Koralov, S.B., Rajewsky, K. and Rao, A. (2015) TET proteins and 5-methylcytosine oxidation in hematological cancers. Immunol. Rev., 263, 6-21.
67. Cimmino, L., Dawlaty, M.M., Ndiaye-Lobry, D., Yap, Y.S., Bakogianni, S., Yu, Y., Bhattacharyya, S., Shaknovich, R., Geng, H., Lobry, C. et al. (2015) TET1 is a tumor suppressor of hematopoietic malignancy. Nat. Immunol., 16, 653-662.
68. Zhao, Z., Chen, L., Dawlaty, M.M., Pan, F., Weeks, O., Zhou, Y., Cao, Z., Shi, H., Wang, J., Lin, L. et al. (2015) Combined loss of Tet1 and Tet2 promotes B cell, but not myeloid malignancies, in mice. Cell Rep., 13, 1692-1704.